NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · Real-Time Price · USD
4.388
-0.033 (-0.74%)
Feb 21, 2025, 4:00 PM EST - Market closed
NeuroMetrix Employees
NeuroMetrix had 26 employees as of December 31, 2023. The number of employees decreased by 1 or -3.70% compared to the previous year.
Employees
26
Change (1Y)
-1
Growth (1Y)
-3.70%
Revenue / Employee
$144,914
Profits / Employee
-$295,203
Market Cap
8.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
NURO News
- 6 weeks ago - NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO - Business Wire
- 2 months ago - NeuroMetrix to be Acquired by electroCore - GlobeNewsWire
- 6 months ago - NeuroMetrix Reiterates its Review of Strategic Alternatives - GlobeNewsWire
- 7 months ago - NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - GlobeNewsWire
- 10 months ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 11 months ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire